Suven Life Sciences Ltd.

NSE: SUVEN | BSE: 530239 | ISIN: INE495B01038 | Industry: Healthcare Services
|
230.1300 -2.17 (-0.93%)
NSE Sep 23, 2025 10:22 AM
Volume: 80,225
 

230.13
-0.93%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research We met the management of Suven Life Sciences (Suven) to understand the business model and its future plans. The company offers new chemical (NCE) based contract research & manufacturing services (CRAMS) across the value chain in drug discovery, development, manufacturing and support services in collaboration with leading global life science players. The company generated ~94% of its revenues in H1FY18 from NCE CRAMS business and the rest from technical services....
Suven Life Sciences Ltd. has gained 51.45% in the last 1 Year
More from Suven Life Sciences Ltd.
Recommended